Rachel B. Keller

629 total citations
14 papers, 261 citations indexed

About

Rachel B. Keller is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Rachel B. Keller has authored 14 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 4 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Rachel B. Keller's work include Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Rachel B. Keller is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Rachel B. Keller collaborates with scholars based in United States, Australia and Palestinian Territory. Rachel B. Keller's co-authors include George K. Asdourian, Inga Hofmann, David A. Williams, G. Naheed Usmani, Suneet Agarwal, Raj P. Kapur, Peter H. Byers, Shawna M. Pyott, Michael J. Bamshad and Melanie Pepin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Rachel B. Keller

13 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel B. Keller United States 7 129 87 64 51 44 14 261
Satu‐Leena Sallinen Finland 8 151 1.2× 40 0.5× 101 1.6× 92 1.8× 95 2.2× 10 362
Yajuan Cui China 10 186 1.4× 50 0.6× 17 0.3× 49 1.0× 34 0.8× 25 356
Se Gwang Jang South Korea 11 159 1.2× 81 0.9× 30 0.5× 27 0.5× 50 1.1× 16 316
Timothy Lax United States 8 123 1.0× 33 0.4× 63 1.0× 19 0.4× 47 1.1× 10 314
Lucie Lanikova Czechia 9 136 1.1× 37 0.4× 43 0.7× 60 1.2× 21 0.5× 17 236
Xiuzhi Ren China 10 130 1.0× 25 0.3× 141 2.2× 37 0.7× 33 0.8× 30 257
Nicola Alesi United States 7 104 0.8× 140 1.6× 22 0.3× 15 0.3× 58 1.3× 11 260
Gemma D’Elia Italy 8 210 1.6× 18 0.2× 97 1.5× 134 2.6× 24 0.5× 10 333
Magdalena Koczkowska Poland 12 157 1.2× 17 0.2× 118 1.8× 88 1.7× 76 1.7× 29 310
Andrés López‐Hernandez Spain 4 74 0.6× 96 1.1× 26 0.4× 7 0.1× 61 1.4× 5 224

Countries citing papers authored by Rachel B. Keller

Since Specialization
Citations

This map shows the geographic impact of Rachel B. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel B. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel B. Keller more than expected).

Fields of papers citing papers by Rachel B. Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel B. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel B. Keller. The network helps show where Rachel B. Keller may publish in the future.

Co-authorship network of co-authors of Rachel B. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel B. Keller. A scholar is included among the top collaborators of Rachel B. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel B. Keller. Rachel B. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lin, Douglas I., Richard S.P. Huang, Ioannis Ladas, et al.. (2024). Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers. Frontiers in Oncology. 14. 1328512–1328512. 1 indexed citations
2.
Pathak, Priyadarshini, Gerald Li, Júlia C.F. Quintanilha, et al.. (2024). Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with metastatic pancreatic cancer.. Journal of Clinical Oncology. 42(3_suppl). 621–621. 3 indexed citations
3.
Keller, Rachel B., James Haberberger, Alexa B. Schrock, et al.. (2023). Abstract 305: POLE-specific variant classification strategy is critical for identifying patients who may benefit from immunotherapy. Cancer Research. 83(7_Supplement). 305–305.
4.
Quintanilha, Júlia C.F., Ryon P. Graf, Gerald Li, et al.. (2023). Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness. JCO Precision Oncology. 7(7). 26–27. 31 indexed citations
5.
Tung, Nadine, Hanna Tukachinsky, Erica Gornstein, et al.. (2023). Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing. npj Precision Oncology. 7(1). 76–76. 15 indexed citations
6.
Tran, Thao, Rachel B. Keller, Brecht Guillemyn, et al.. (2021). Biallelic variants in MESD, which encodes a WNT-signaling-related protein, in four new families with recessively inherited osteogenesis imperfecta. SHILAP Revista de lepidopterología. 2(4). 100051–100051. 6 indexed citations
7.
Mazor, Tali, Rachel B. Keller, James Lindsay, et al.. (2020). Abstract 3382: MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials. Cancer Research. 80(16_Supplement). 3382–3382. 1 indexed citations
8.
Dale, Beverly A. & Rachel B. Keller. (2019). Advancing Sexual Health for the Christian Client. 4 indexed citations
9.
Mazor, Tali, Rachel B. Keller, Priti Kumari, et al.. (2019). Abstract A024: MatchMiner: An open-source computational platform for genomically-driven matching of cancer patients to precision medicine clinical trials. Molecular Cancer Therapeutics. 18(12_Supplement). A024–A024. 1 indexed citations
10.
Keller, Rachel B., Thao Tran, Shawna M. Pyott, et al.. (2017). Monoallelic and biallelic CREB3L1 variant causes mild and severe osteogenesis imperfecta, respectively. Genetics in Medicine. 20(4). 411–419. 51 indexed citations
11.
Strub, Graham M., Mark Whipple, Winston Patrick Kuo, et al.. (2016). Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma. JCI Insight. 1(14). e88856–e88856. 41 indexed citations
12.
Keller, Rachel B., Dina El Demellawy, Alberto Quaglia, Milton J. Finegold, & Raj P. Kapur. (2015). Methylation Status of the Chromosome Arm 19q MicroRNA Cluster in Sporadic and Androgenetic-Biparental Mosaicism–Associated Hepatic Mesenchymal Hamartoma. Pediatric and Developmental Pathology. 18(3). 218–227. 13 indexed citations
13.
Keller, Rachel B., et al.. (2015). Glass Debris Field Longevity for Rollover Accident Reconstruction. SAE technical papers on CD-ROM/SAE technical paper series. 1. 2 indexed citations
14.
Keller, Rachel B., G. Naheed Usmani, George K. Asdourian, et al.. (2012). CTC1 Mutations in a patient with dyskeratosis congenita. Pediatric Blood & Cancer. 59(2). 311–314. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026